- Home
- CHRS vs RRGB Comparison
CHRS vs RRGB Comparison
Compare CHRS & RRGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- RRGB
- Stock Information
- Founded
- CHRS 2010
- RRGB 1969
- Country
- CHRS United States
- RRGB United States
- Employees
- CHRS N/A
- RRGB N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- RRGB Restaurants
- Sector
- CHRS Health Care
- RRGB Consumer Discretionary
- Exchange
- CHRS Nasdaq
- RRGB Nasdaq
- Market Cap
- CHRS 102.0M
- RRGB 88.7M
- IPO Year
- CHRS 2014
- RRGB 2002
- Fundamental
- Price
- CHRS $1.04
- RRGB $6.79
- Analyst Decision
- CHRS Buy
- RRGB Strong Buy
- Analyst Count
- CHRS 3
- RRGB 4
- Target Price
- CHRS $4.68
- RRGB $12.38
- AVG Volume (30 Days)
- CHRS 1.3M
- RRGB 318.3K
- Earning Date
- CHRS 08-07-2025
- RRGB 08-21-2025
- Dividend Yield
- CHRS N/A
- RRGB N/A
- EPS Growth
- CHRS N/A
- RRGB N/A
- EPS
- CHRS N/A
- RRGB N/A
- Revenue
- CHRS $272,251,000.00
- RRGB $1,252,370,000.00
- Revenue This Year
- CHRS N/A
- RRGB N/A
- Revenue Next Year
- CHRS $99.43
- RRGB N/A
- P/E Ratio
- CHRS $2.44
- RRGB N/A
- Revenue Growth
- CHRS 19.87
- RRGB N/A
- 52 Week Low
- CHRS $0.66
- RRGB $2.50
- 52 Week High
- CHRS $2.43
- RRGB $7.89
- Technical
- Relative Strength Index (RSI)
- CHRS 68.96
- RRGB 59.21
- Support Level
- CHRS $0.88
- RRGB $6.77
- Resistance Level
- CHRS $1.06
- RRGB $7.89
- Average True Range (ATR)
- CHRS 0.07
- RRGB 0.44
- MACD
- CHRS 0.02
- RRGB 0.03
- Stochastic Oscillator
- CHRS 93.38
- RRGB 51.54
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.